Physician profile
Eric L Hanson
NPI 1740259035
$6,416.88
in general payments reported to CMS, 2019-2025
19 companies · $965 in 2025
The $965 reported for 2025 was more than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $23.07 · 2021: $394 · 2022: $806 · 2023: $1,954 · 2024: $1,810 · 2025: $965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,515 · Education: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,514.90 |
| Education | $214.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,961.57 | 2019-2025 | |
| Janssen Biotech, INC. | $743.71 | 2023-2025 | Tremfya, Simponi, Stelara |
| Genzyme Corporation | $562.66 | 2019-2025 | |
| Lilly USA, LLC | $511.31 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Pfizer INC. | $451.99 | 2022-2024 | |
| E.R. Squibb & Sons, L.L.C. | $382.46 | 2022-2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $236.33 | 2019-2025 | Dupixent |
| Amgen INC. | $88.70 | 2022-2024 | Otezla |
| Incyte Corporation | $81.11 | 2022-2025 | Opzelura |
| Ucb, INC. | $77.82 | 2025 | Bimzelx |
| Advanced Medical Administration | $68.50 | 2025 | Amniograft |
| Organon LLC | $61.18 | 2024-2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $50.23 | 2024-2025 | Zoryve |
| Galderma Laboratories, L.P. | $36.94 | 2021-2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $32.14 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $23.15 | 2023 | Idacio |
| Strata Skin Sciences, INC. | $18.29 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.09 | 2025 | Cabtreo, Jublia, Siliq |
| Biofrontera INC. | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.